LGALS9 and hepatocellular carcinoma: Concomitant pre-operative high levels of Gal-9 and PD-L1 in both tumour tissue and circulation, associated with high CD8+ TIL counts, predicted very accurately an improved overall and recurrence-free survival in hepatocellular carcinoma (HCC) (110).